Induced neural stem/precursor cells for fundamental studies and potential application in neurodegenerative diseases

Ting Shen1, Jiali Pu1, Tingting Zheng1

  • 1Department of Neurology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310009, China.

Neuroscience Bulletin
|June 17, 2015
PubMed

Insights

Defined factors convert somatic cells into induced neural stem cells (iNSCs/iNPCs) via transdifferentiation. This bypasses pluripotency, reducing risks and offering potential for regenerative medicine and disease modeling in neurodegenerative conditions.

Area of Science:

  • Biotechnology
  • Stem Cell Biology
  • Neuroscience

Background:

  • Somatic cells can be directly converted into induced neural stem cells or neural precursor cells (iNSCs/iNPCs) using specific exogenous factors.
  • This transdifferentiation process circumvents a pluripotent stage, mitigating risks of tumorigenesis and genetic instability while preserving self-renewal capacity.

Purpose of the Study:

  • To review the mechanisms, techniques, and applications of iNSC/iNPC technology.
  • To explore novel strategies and potential applications of iNSC/iNPCs in treating neurodegenerative diseases.

Main Methods:

  • Review of existing literature on iNSC/iNPC generation and application.
  • Analysis of transdifferentiation mechanisms bypassing pluripotency.
  • Examination of therapeutic and disease modeling potential.

Main Results:

  • Exogenous factors are sufficient for direct somatic cell conversion to iNSCs/iNPCs.
  • Transdifferentiation offers a safer alternative to pluripotent stem cells for regenerative applications.
  • iNSC/iNPCs show promise for neurodegenerative disease modeling and potential cell replacement therapies.

Conclusions:

  • iNSC/iNPC technology represents a significant advancement in regenerative medicine for neurodegenerative disorders.
  • Direct reprogramming bypasses pluripotency, enhancing safety and therapeutic potential.
  • Further research into novel strategies can unlock the full clinical utility of iNSC/iNPCs.

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.6K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K